EUVIMEDEUVIMED entdecken
Crossref

Cyclin E Expression and p16 Loss Are Strong Prognostic Biomarkers in Primary Invasive Cutaneous Melanoma

Ioannis G Gkionis, Maria Tzardi, Athanasios Alegakis, Galateia Datseri, Eleni Moustou, Georgios Saridakis, Dimosthenis Michelakis, Sabine Kruger-Krasagakis, Konstantinos Krasagakis, Eelco DE Bree

Anticancer Research · 2025

DOI: 10.21873/anticanres.17450 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Ioannis G Gkionis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Venizeleio General Hospital, Heraklion, Greece. Hauptthemen laut MEDLINE: Melanoma, Cyclin E, Biomarkers, Tumor, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaCyclin EBiomarkers, TumorCyclin-Dependent Kinase Inhibitor p16Skin NeoplasmsHumansFemaleMaleMiddle AgedPrognosisAgedAdultAged, 80 and overCutaneous Malignant MelanomaImmunohistochemistryOncogene Proteins

Stichwörter der Autor:innen

Cyclin D1Cyclin EMelanomacyclin-dependent kinase inhibitorscyclinsp16p21p27prognostic biomarkers

Substanzen

Cyclin EBiomarkers, TumorCyclin-Dependent Kinase Inhibitor p16CDKN2A protein, humanCCNE1 protein, humanOncogene Proteins

Autor:innen und Institutionen

  • Department of General Surgery, Venizeleio General Hospital, Heraklion, Greece.
  • School of Medicine, University of Crete, Heraklion, Greece.
  • Department of Pathology, University Hospital of Heraklion, Heraklion, Greece.
  • Department of Surgical Oncology, University Hospital of Heraklion, Heraklion, Greece.
  • Department of Dermatology, University Hospital of Heraklion, Heraklion, Greece.
  • School of Medicine, University of Crete, Heraklion, Greece debree@uoc.gr.

Zitieren

APA

Gkionis, I. G., Tzardi, M., Alegakis, A., Datseri, G., Moustou, E., Saridakis, G., Michelakis, D., Kruger-Krasagakis, S., Krasagakis, K., & DE Bree, E. (2025). Cyclin E Expression and p16 Loss Are Strong Prognostic Biomarkers in Primary Invasive Cutaneous Melanoma. Anticancer Research. https://doi.org/10.21873/anticanres.17450

Vancouver

Gkionis IG, Tzardi M, Alegakis A, Datseri G, Moustou E, Saridakis G, et al. Cyclin E Expression and p16 Loss Are Strong Prognostic Biomarkers in Primary Invasive Cutaneous Melanoma. Anticancer Research. 2025. doi:10.21873/anticanres.17450

BibTeX
@article{Gkionis2025,
  author = {Gkionis, Ioannis G and Tzardi, Maria and Alegakis, Athanasios and Datseri, Galateia and Moustou, Eleni and Saridakis, Georgios and Michelakis, Dimosthenis and Kruger-Krasagakis, Sabine and Krasagakis, Konstantinos and DE Bree, Eelco},
  title = {Cyclin E Expression and p16 Loss Are Strong Prognostic Biomarkers in Primary Invasive Cutaneous Melanoma},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17450}
}
Kostenlos starten →